ＡＮＧＰＴＬ８結合薬及びその使用方法 - NGM By Offer Matthew Tikals, Incorporated

Title:

ＡＮＧＰＴＬ８結合薬及びその使用方法

Document Type and Number:

Japanese Patent JP7291694

Kind Code:

B2

Abstract:

The present disclosure provides binding agents, such as antibodies, that specifically bind Angiopoietin-like protein 8 (ANGPTL8), including human ANGPTL8, and methods of their use.

More Like This:

JP7288943	A novel bispecific antigen-binding molecule capable of specifically binding CD40 and FAP
JP2023519851	Bispecific antibody for use in producing armed immune cells
JP7311425	Bispecific antibody that binds to CD40 and EpCAM

Inventors:

Chu, Chun
Ding, Shunshan
Liu, Zhonghao
One, Yang
Inn, Yiyuan
Jai, Wenwu

Application Number:

JP2020524144A

Publication Date:

June 15, 2023

Filing Date:

November 08, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

NGM By Offer Matthew Tikals, Incorporated

International Classes:

C12N15/13; A61K39/395; A61P1/18; A61P3/00; A61P3/04; A61P3/06; A61P3/10; A61P5/14; A61P9/00; A61P13/12; A61P43/00; C07K16/18; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63

Foreign References:

US20170037124
WO2017177181A1

Other References:

Fu, Z., et al.,A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase,Sci Rep,5:18502,2015年12月21日,pp.1-9

Attorney, Agent or Firm:

Shusaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto

Previous Patent: 棚のための支承構造

Next Patent: HYDRAULIC INORGANIC COMPOSITION FOR DEHYDRATING PRESS MOLDING AND PRODUCTION OF HYDRAULIC INORGANIC ...